Invesaro

Stocks Comparison

Johnson & Johnson vs ELI LILLY: revenue, profit, margins and growth compared

Johnson & Johnson brought in $94.2B of revenue in fiscal 2025, ELI LILLY $65.2B in fiscal 2025. Revenue changed by +6.0% at Johnson & Johnson and +44.7% at ELI LILLY on the year before, so ELI LILLY grew faster. Johnson & Johnson kept 28.5% of its revenue as net profit, ELI LILLY 31.7%.

Side by side, latest fiscal year

JNJLLY
Fiscal year endedFY2025 (December 28, 2025)FY2025 (December 31, 2025)
Revenue$94.2B$65.2B
Revenue growth+6.0%+44.7%
Net income$26.8B$20.6B
Net margin28.5%31.7%
Free cash flow$19.7Bn/a
Free cash flow margin20.9%n/a
Earnings per share (diluted)$11.03$22.95
Cash$19.7B$7.3B
Debt$41.4B$40.9B
Price to earnings24.651.6
Market value$653.6B$1.11T
Dividend yield1.90%0.53%
Rank by revenue in sector#9 of 523 · Health care#11 of 523 · Health care

Over the years

Revenue
JNJ FY2018: $81.6BJNJ FY2019: $82.1BJNJ FY2020: $82.6BJNJ FY2021: $78.7BJNJ FY2022: $80BJNJ FY2023: $85.2BJNJ FY2024: $88.8BJNJ FY2025: $94.2BLLY FY2018: $21.5BLLY FY2019: $22.3BLLY FY2020: $24.5BLLY FY2021: $28.3BLLY FY2022: $28.5BLLY FY2023: $34.1BLLY FY2024: $45BLLY FY2025: $65.2BFY18FY19FY20FY21FY22FY23FY24FY25
JNJ $94.2BLLY $65.2B
Net income
JNJ FY2018: $15.3BJNJ FY2019: $15.1BJNJ FY2020: $14.7BJNJ FY2021: $20.9BJNJ FY2022: $17.9BJNJ FY2023: $35.2BJNJ FY2024: $14.1BJNJ FY2025: $26.8BLLY FY2018: $3.2BLLY FY2019: $8.3BLLY FY2020: $6.2BLLY FY2021: $5.6BLLY FY2022: $6.2BLLY FY2023: $5.2BLLY FY2024: $10.6BLLY FY2025: $20.6BFY18FY19FY20FY21FY22FY23FY24FY25
JNJ $26.8BLLY $20.6B
Net margin
JNJ FY2018: 18.8%JNJ FY2019: 18.4%JNJ FY2020: 17.8%JNJ FY2021: 26.5%JNJ FY2022: 22.4%JNJ FY2023: 41.3%JNJ FY2024: 15.8%JNJ FY2025: 28.5%LLY FY2018: 15.0%LLY FY2019: 37.3%LLY FY2020: 25.2%LLY FY2021: 19.7%LLY FY2022: 21.9%LLY FY2023: 15.4%LLY FY2024: 23.5%LLY FY2025: 31.7%FY18FY19FY20FY21FY22FY23FY24FY25
JNJ 28.5%LLY 31.7%
Revenue growth
JNJ FY2019: +0.6%JNJ FY2020: +0.6%JNJ FY2021: -4.7%JNJ FY2022: +1.6%JNJ FY2023: +6.5%JNJ FY2024: +4.3%JNJ FY2025: +6.0%LLY FY2019: +3.8%LLY FY2020: +9.9%LLY FY2021: +15.4%LLY FY2022: +0.8%LLY FY2023: +19.6%LLY FY2024: +32.0%LLY FY2025: +44.7%FY19FY20FY21FY22FY23FY24FY25
JNJ +6.0%LLY +44.7%
Free cash flow
JNJ FY2018: $18.5BJNJ FY2019: $19.9BJNJ FY2020: $20.2BJNJ FY2021: $19.8BJNJ FY2022: $17.2BJNJ FY2023: $18.2BJNJ FY2024: $19.8BJNJ FY2025: $19.7BFY18FY19FY20FY21FY22FY23FY24FY25
JNJ $19.7BLLY

Fiscal years as each company reports them; the two may end in different months.

Questions about Johnson & Johnson and ELI LILLY

Which is bigger by revenue, Johnson & Johnson or ELI LILLY?

Johnson & Johnson is bigger by revenue: $94.2B in fiscal 2025, against $65.2B for ELI LILLY in fiscal 2025.

Which keeps more of its revenue as profit, Johnson & Johnson or ELI LILLY?

Johnson & Johnson had a net margin of 28.5% in fiscal 2025; ELI LILLY had 31.7% in fiscal 2025.

Which grew revenue faster, Johnson & Johnson or ELI LILLY?

In their latest fiscal years revenue changed by +6.0% at Johnson & Johnson and +44.7% at ELI LILLY.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies